{"id":"W2783057186","doi":"10.1017/s0266462317003968","title":"VP157 What Is The Response To Immuno-Oncology By Health Technology Assessment Agencies?","year":2017,"lang":"en","type":"article","venue":"International Journal of Technology Assessment in Health Care","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Ipilimumab; Medicine; Nivolumab; Reimbursement; Context (archaeology); Family medicine; Health technology; Pembrolizumab; Health care; Nice; Biosimilar; Oncology; Internal medicine; Cancer; Immunotherapy; Political science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08620694,0.0003285244,0.000859023,0.002950891,0.001444501,0.01089053,0.001553085,0.003022047,0.0116315],"category_scores_gemma":[0.3200468,0.0004575998,0.001858611,0.005312047,0.002301405,0.004779648,0.00208484,0.002854256,0.001338248],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01264379,"about_ca_system_score_gemma":0.01233555,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01756347,"about_ca_topic_score_gemma":0.01320329,"domain_scores_codex":[0.8692777,0.08285043,0.006613664,0.006148367,0.02943989,0.005669975],"domain_scores_gemma":[0.5305649,0.3290009,0.07379835,0.00761503,0.05139518,0.007625699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001782592,0.0006244608,0.7474571,0.002768428,0.001525206,0.0005707675,0.002334599,0.01112881,0.0008986646,0.04916651,0.05144158,0.1303012],"study_design_scores_gemma":[0.0008171882,0.001464245,0.7094515,0.004068267,0.0009928287,0.0005629198,0.0159599,0.01736755,0.002735654,0.02712642,0.2191818,0.0002717322],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5942609,0.01323984,0.00591755,0.2052588,0.000937183,0.002146862,0.01341959,0.00009494522,0.1647244],"genre_scores_gemma":[0.9766924,0.002199597,0.002928165,0.01269913,0.000414921,0.0004501278,0.001620829,0.00003919074,0.00295554],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08620694,"threshold_uncertainty_score":0.4559113,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1776119165358474,"score_gpt":0.5360692325785357,"score_spread":0.3584573160426883,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}